DAB2IP and cancer: DAB2IP expression is frequently reduced in tumors by promoter methylation; in addition, post-transcriptional mechanisms of inactivation in cancer and stromal cells have been reported: these include repression by microRNAs, formation of aberrant protein complexes, and possibly increased degradation [12,13,16].